Active substance

Haemagglutininum influenzae A (H1N1) (Virus Stamm A/Missouri/11/2025 (H1N1)pdm09-like: reassortant virus IVR-278 derived from A/Switzerland/6849/2025) + Haemagglutininum influenzae A (H3N2) (Virus Stamm A/Darwin/1454/2025 (H3N2)-like: reassortant virus SAN-049A derived from A/Michigan/105/2025) + Haemagglutininum influenzae B (Virus Stamm B/Tokyo/EIS13-175/2025-like: B/Tokyo/EIS13-175/2025 + Wild type (Victoria lineage))

1 products from 1 companies contain this in Switzerland.

1 prescription only

Prescription only

FluarixPrescription only GlaxoSmithKline AG · Haemagglutininum influenzae A (H1N1) (Virus Stamm A/Missouri/11/2025 (H1N1)pdm09-like: reassortant virus IVR-278 derived from A/Switzerland/6849/2025) + Haemagglutininum influenzae A (H3N2) (Virus Stamm A/Darwin/1454/2025 (H3N2)-like: reassortant virus SAN-049A derived from A/Michigan/105/2025) + Haemagglutininum influenzae B (Virus Stamm B/Tokyo/EIS13-175/2025-like: B/Tokyo/EIS13-175/2025 + Wild type (Victoria lineage)) · J07BB02

Same substance is not the same product. Strength, form, release mechanism and other ingredients all differ. Whether one can replace another is a decision for a pharmacist.